Fate Therapeutics
FATE
#9044
Rank
โ‚ฌ0.10 B
Marketcap
0,93ย โ‚ฌ
Share price
-1.82%
Change (1 day)
-63.02%
Change (1 year)

Market capitalization of Fate Therapeutics (FATE)

Market cap: โ‚ฌ0.10 Billion

As of December 2025 Fate Therapeutics has a market cap of โ‚ฌ0.10 Billion. This makes Fate Therapeutics the world's 9044th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Fate Therapeutics from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ0.10 B-39.28%
2024โ‚ฌ0.17 B-47.18%
2023โ‚ฌ0.33 B-63.5%
2022โ‚ฌ0.91 B-81.47%
2021โ‚ฌ4.93 B-23.51%
2020โ‚ฌ6.44 B387.52%
2019โ‚ฌ1.32 B82.34%
2018โ‚ฌ0.72 B170.67%
2017โ‚ฌ0.26 B171.43%
2016โ‚ฌ98.75 M11.58%
2015โ‚ฌ88.5 M4.04%
2014โ‚ฌ85.07 M-8.45%
2013โ‚ฌ92.92 M

End of Day market cap according to different sources

On Dec 6th, 2025 the market cap of Fate Therapeutics was reported to be:

โ‚ฌ0.10 Billion
by Nasdaq info icon info icon
โ‚ฌ0.10 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sarepta Therapeutics
SRPT
โ‚ฌ2.00 B 1,772.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
โ‚ฌ47.74 B 44,525.18%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
โ‚ฌ5.32 B 4,878.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
โ‚ฌ9.27 B 8,563.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚ฌ13.31 B 12,345.96%๐Ÿ‡บ๐Ÿ‡ธ USA